1. Home
  2. NVCR vs BLBD Comparison

NVCR vs BLBD Comparison

Compare NVCR & BLBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • BLBD
  • Stock Information
  • Founded
  • NVCR 2000
  • BLBD 1927
  • Country
  • NVCR Jersey
  • BLBD United States
  • Employees
  • NVCR N/A
  • BLBD N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • BLBD Construction/Ag Equipment/Trucks
  • Sector
  • NVCR Health Care
  • BLBD Consumer Discretionary
  • Exchange
  • NVCR Nasdaq
  • BLBD Nasdaq
  • Market Cap
  • NVCR 1.8B
  • BLBD 1.5B
  • IPO Year
  • NVCR 2015
  • BLBD N/A
  • Fundamental
  • Price
  • NVCR $17.09
  • BLBD $40.08
  • Analyst Decision
  • NVCR Buy
  • BLBD Strong Buy
  • Analyst Count
  • NVCR 5
  • BLBD 7
  • Target Price
  • NVCR $26.60
  • BLBD $60.14
  • AVG Volume (30 Days)
  • NVCR 885.3K
  • BLBD 890.4K
  • Earning Date
  • NVCR 10-30-2024
  • BLBD 11-25-2024
  • Dividend Yield
  • NVCR N/A
  • BLBD N/A
  • EPS Growth
  • NVCR N/A
  • BLBD N/A
  • EPS
  • NVCR N/A
  • BLBD 3.02
  • Revenue
  • NVCR $577,738,000.00
  • BLBD $1,299,905,000.00
  • Revenue This Year
  • NVCR $19.13
  • BLBD $18.91
  • Revenue Next Year
  • NVCR $5.33
  • BLBD $10.10
  • P/E Ratio
  • NVCR N/A
  • BLBD $13.01
  • Revenue Growth
  • NVCR 14.63
  • BLBD 19.53
  • 52 Week Low
  • NVCR $11.29
  • BLBD $17.79
  • 52 Week High
  • NVCR $24.74
  • BLBD $59.40
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 52.30
  • BLBD 44.61
  • Support Level
  • NVCR $15.35
  • BLBD $36.86
  • Resistance Level
  • NVCR $17.35
  • BLBD $43.01
  • Average True Range (ATR)
  • NVCR 0.98
  • BLBD 2.22
  • MACD
  • NVCR -0.06
  • BLBD -0.05
  • Stochastic Oscillator
  • NVCR 52.41
  • BLBD 47.51

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About BLBD Blue Bird Corporation

Blue Bird Corp is an American bus manufacturing company. It has its operations in two segments. The Bus segment involves the design, engineering, manufacture and sales of school buses and extended warranties; and the Parts segment which includes the sales of replacement bus parts. It carries its operations in the United States, Canada, and the rest of the world. The majority of its sales are derived from the United States through its bus manufacturing business.

Share on Social Networks: